Skip to main content

Table 1 Comparison of the number of significant pairs.

From: Integrated analysis of microRNA-target interactions with clinical outcomes for cancers

  Num of Significant Pairs (p-value < 0.01) HH:LL HL:LH HH:HL HH:LH LL:LH LL:HL
Ovarian
Cancer
Validation Pair 257 261 113 200 143 248
  Total Pair 22,685 22,575 9,408 18,739 10,299 21,332
GBM Validation Pair 234 250 229 171 161 229
  Total Pair 47,706 51,217 22,180 36,023 22,835 42,735
  1. Comparison of the number of significant pairs (p-value <0.01) in total and validation for six pairwise survival test sets.